Post-mortem brain tissue provides a unique opportunity to uncover the genes or proteins involved in the pathophysiology of neuropsychiatric disorders. Protein phosphorylation is a common protein modification within intracellular signaling pathways that affects the distribution and function of protein, and has been hypothesized to be of major importance in both the pathophysiology and treatment of major neuropsychiatric disorders. Thus, we were interested in ascertaining the stability of the phosphorylated forms of proteins that are involved in cellular signaling. Antibodies against phospho-tyrosine, phospho-threonine, and phospho-PKA substrates were used to examine the PMI effects on the general amounts of proteins in their phosphorylated form. Phospho-specific antibodies for ERK, JNK, RSK, CREB, and ATF-2 were used to test the effects of PMI on specific proteins whose functioning are known to be regulated markedly by phosphorylation. We found that PMI rapidly decreased the levels of proteins in their phosphorylated states and also decreased the total levels of certain proteins. The PMI effects were observed in the samples stored at both 41C and room temperature, in both frontal cortex and hippocampus. Thus, it appears that measurements (such as two-dimensional gel electrophoresis and functional assays) that rely on the phosphorylation state of proteins would be extremely sensitive to PMI.
INTRODUCTION
Post-mortem brain tissue is increasingly being utilized to study the molecular and cellular pathophysiology of neuropsychiatric disorders. Analysis of post-mortem brains has proven invaluable in helping to uncover the neuropathology of numerous diseases, including Alzheimer's, Huntington's, and Parkinson's disease; indeed, these studies have facilitated the elucidation of the central pathophysiology of these illnesses (Greenfield et al, 1997) . While these diseases show anatomical changes that are identifiable by gross post-mortem brain examination, there may exist more subtle cellular and molecular changes in the brains of patients with other neuropsychiatric disorders, including bipolar disorder, unipolar depression, and schizophrenia Harrison, 1996 Harrison, , 1999 Harrison, , 2002 Knable and Webster, 2001; Rajkowska, 2002; Vawter et al, 2000) . Thus, post-mortem brain specimens represent an invaluable resource to investigate the pathophysiology of these, and numerous other, neuropsychiatric illnesses.
There are many confounding factors that effect the outcome of post-mortem measurements including the post-mortem interval (PMI), cerebral hemisphere selected, method of sampling and storing tissue, anatomical precision during dissection, histological processing technique, age, gender, general health preceding death (agonal state, which is generally related to brain pH), neurological and psychiatric state, medication, time of day of death (circadian state), and date of death (seasonal state) (Lewis, 2002; Perry and Perry, 1983; Ravid et al, 1992) .
The PMI is the period from death to freezing of brain specimens for long-term storage at À801C (Harrison and Kleinman, 2000) , and may be one of the more important variables (Dodd et al, 1988) . Most protocols and brain banks that supply post-mortem brains for analysis attempt to keep the PMI as short, and as uniform, as possible. Unfortunately, given the difficulty in collecting postmortem brain samples, it is often impossible to avoid long and often variable PMIs. The problem with PMIs may be more pronounced in the study of illnesses like bipolar disorder, depression, and schizophrenia, in which individuals generally die 'unexpectedly', and outside of a wellmonitored long-term care facility, thus resulting in a relatively long PMI. Furthermore, it is often difficult to ascertain exactly when expiration occurred, leading to inaccuracies in PMI estimates.
The phosphorylation of cellular signaling proteins has been implicated in the pathophysiology of numerous neuropsychiatric diseases Jope, 1999; Konradi and Heckers, 2001; Lenox and Hahn, 2000; Maccioni et al, 2001) . Indeed, the phosphorylated form of a protein is clearly of major biological interest; it often affects the function and/or subcellular distribution of enzymes, receptors, neurotransmitter transporters, ion channels, and transcription factors. Thus, the ability to measure phosphorylated proteins in their native state could facilitate post-mortem investigations of neuropsychiatric disorders. Phosphorylation also effects the migration of proteins during two-dimensional gel electrophoresis (Sickmann and Meyer, 2001 ), a technique that may be useful for analyzing disease-specific changes in post-mortem brain specimens (Edgar et al, 1999; Fountoulakis et al, 2001; Johnston-Wilson et al, 2000) . For these reasons, we investigated the effects of PMI on protein phosphorylation state in mouse brain tissue, where we can control exactly the PMI and are assured minimal genetic/tissue heterogeneity by utilizing inbred strains. We chose proteins based upon their putative involvement in the pathophsyiology and treatment of mood disorders , and their specificity for different phospho-amino acids (see Materials and methods section). We found that PMI produced profound and relatively rapid effects on the phosphorylation of proteins involved in intracellular signaling.
MATERIALS AND METHODS
Male C57/BL6 mice 6-7 weeks of age from Harlan (B20 g) were housed 4-5 per cage in a 12 h light/dark cycle with free access to water and food. All mice were killed by decapitation between 9 and 10 am. Heads of animals were covered or placed in a small plastic bag, and stored at either room temperature or at 41C. Frontal cortex and hippocampus were dissected on ice immediately, 4, 8, 14, 24, 36, 48 h (or 8, 24 , and 48 for the room temperature storage) following decapitation. Immediately after dissection, brain specimens were rapidly frozen in dry ice and stored at À801C until further analyses. The frontal cortex and hippocampus samples were homogenized by sonication in a protein extraction buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, protease inhibitor cocktail (SIGMA), and phosphatase inhibitor cocktail I and II (SIGMA). The homogenates were then centrifuged at 14 000 g for 10 s to remove undissolved debris. Protein concentrations were determined using the Bio-Rad protein assay kit (Bradford, 1976) . The linearity of the protein concentration for immunoblotting for each protein was ascertained by resolution of selected concentrations of protein.
Subsequent protein immunoblotting was performed using previously described methods (Yuan et al, 2001) . In brief, samples were subjected to SDS-PAGE. The amount of protein loaded was 40 mg per lane, except for p-ERK, ERK, Bcl-2, and Bcl-x, for which 10 mg was loaded. Proteins thus resolved were then electrophoretically transferred to nitrocellulose membranes. Nonspecific binding on the nitrocellulose was blocked with 5% nonfat dry milk/TBST, and then incubated with a primary antibody. Primary antibodies were either from Cell Signaling Technology (p-PKA substrate (catalog 9621), p-tyrosine (9411) 
RESULTS
Mice were sacrificed, and stored at room temperature in 0, 8, 24, or 48 h prior to dessection. We initially examined the effects of PMI on total phosphorylated proteins using antibodies specific for the phosphorylation of specific amino acids, but not specific for individual proteins or the surrounding amino-acid sequence. Antibodies specific for phospho-tyrosine and phospho-threonine containing proteins revealed that PMI reduced the phosphorylation of the majority of these substrates (Figure 1a, b) . Similar results were obtained using an antibody for the phosphorylated forms of potential phospho-protein kinase A (PKA) substrates ( Figure 1c ). We were additionally interested if PMI had an effect on other post-translational modifications. To test this, we used an antibody specific for acetylated-lysine containing proteins. Among a limited number of primary bands, the PMI reduced levels of band C, and altered the levels of band B in a tri-phasic manner (Figure 1d ).
We next investigated whether the PMI changes the phosphorylation state of specific protein where phosphorylation is known to affect directly protein function. Protein kinases extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and transcription factors cJun, cyclic AMP response element binding protein (CREB) and activating transcription factor-2 (ATF-2) were selected for the study since alterations in the functions of these molecules have been implicated in the treatment and pathophysiology of mood disorders . In samples stored at room temperature, the earliest PMI (8 h) had a dramatic effect on the levels of all phosphophorylated proteins as measured by immunoblotting (Figures 2-5, panels a and b) . In contrast to the rather consistent results obtained using phospho-specific antibodies, there was variability of the effect of PMI on the total levels of proteins analyzed (Figures 2-6 , panels a and b). Thus, PMI decreased the levels of some proteins as revealed by immunoblotting; however, others were not significantly changed using our methods. All experiments were repeated with samples from the hippocampus, with findings similar to those shown in Figures 2-6 (data not shown). Since the PMI often encompasses time in refrigeration, we repeated the experiments; however, the brains were placed immediately at 41C after mice were sacrificed, and additional time points were used (0, 4, 8, 14, 24, 36 , and 48 h). In general, results at 41C were similar to those obtained at room temperature. The earliest PMI (4 h) had a dramatic effect on the levels of all phosphorylated proteins (Figures 2-5 , panels c and d). Consistent with the results obtained when brains were stored at room temperature, there was variability on the effect of PMI on the total levels of proteins analyzed (Figures 2-6, panels c and d) . PMI decreased the levels of many proteins, but other protein levels were unchanged. The proteins that decreased in immunolabelingFor remained stableFafter storage at room temperature were similar to those that were stored at 41C. For example, PMI had an effect on the protein levels of C-Jun ( 
DISCUSSION
PMI has a major impact on the levels of proteins in the phosphorylated (often functional) state as detected by immunoblot (Figures 1-5) . Furthermore, PMI decreased the total level of some proteins (Figures 2-6 ). Storage of brains at 41C did not appear to affect the decrease in phospho-protein levels; however, it did appear to delay the degradation of some total proteins (Figures 2-6 ). Phosphorylation of the tau protein has been investigated in a number of studies; these studies have shown that while phosphorylation of most sites on tau are highly unstable during the PMI, some appear not to be affected to the same degree (Burack and Halpain, 1996; Gartner et al, 1998; Matsuo et al, 1994; Song et al, 1997) . Our data are generally consistent withFand extendsFthis series of findings, suggesting that it may be difficult to measure the level of most phosphoproteins that are involved in intracellular signaling in post-mortem human brain specimens (where the average PMI is often longer than 24 h). However, considering that nonprotein-specific phospho-antibodies appeared to identify some phosphorylated proteins unaffected by PMI (Figure 1) , it is possible that not all phosphorylated proteins are affected to such a degree (Walaas et al, 1989) . Furthermore, as many enzymes are regulated by phosphorylation, it may be difficult to measure reliably the in vitro activity (as a correlate of in vivo activity) of many enzymes from the post-mortem brain. Indeed, numerous studies have found that the activities of certain enzymes are sensitive to PMI (Bowen et al, 1976; Puymirat et al, 1979; Roytta et al, 1980; Spokes and Koch, 1978) ; our data suggest a possible mechanism underlying these findings. Clearly, as witnessed by the relative stability of the total level of some proteins compared to others among our data, there is considerable variability of the PMI stability of total protein levels. This finding is consistent with previous studies addressing the stability of other biological products such as protein levels (Akil and Lewis, 1994; Fountoulakis et al, 2001; Geddes et al, 1995; Li et al, 1996; Schwab et al, 1994) , mRNA (Burke et al, 1991; Finger et al, 1987; Pardue et al, 1994; Schramm et al, 1999) , ligand binding (Kornhuber et al, 1988) , monoamine levels (Spokes and Koch, 1978) , and enzyme activity (Bowen et al, 1976; Puymirat et al, 1979; Roytta et al, 1980; Spokes and Koch, 1978) in brain specimens; while findings for a specific measure are generally reproducible among studies, there is variability among members of the same class (ie different mRNAs, enzymes, etc). Thus, it cannot be assumed that because one particular protein, mRNA, etc is stable, all are stable during a certain PMI. In addition to PMI and storage temperature, other factors such as agonal state at death (Bowen et al, 1976; Butterworth et al, 1983; Harrison et al, 1991; Lewis and Akil, 1997; Perry et al, 1977a Perry et al, , 1982 Spokes, 1979; Yates et al, 1990) , pH (generally related to agonal state) (Barton et al, 1993; Eastwood and Harrison, 2000; Harrison et al, 1995; Johnston et al, 1997; Kingsbury et al, 1995) , freezing time (Roytta et al, 1980) , and time or season of death (Bucht et al, 1981; Carlsson et al, 1980 ; Perry et al, 1977a-d), among many others, have been found to influence the degradationFor levelFof biological products in postmortem brain specimens. Thus, it remains critical to ascertain the post-mortem stability, and the stability under other conditions, of the biological product. While important, post hoc correlational analysis may not always be indicative of the stability of proteins. There is likely a greater relative variation in post-mortem human specimensFas opposed to animal modelsFbecause of the factors discussed in this manuscript, and/or the relative genetic and environmental heterogeneity found in humans. Furthermore, as has recently been articulated, it is quite possible that the biological measure had already changed substantially from the in vivo value and that within the PMI of post-mortem brain specimens (12-48 h) there is little variation (Lewis, 2002) . As previously suggested (Lewis, 2002; Lewis and Akil, 1997; Perry and Perry, 1983; Spokes and Koch, 1978) , it may be advisable to testFin experimental animal modelsFthe stability of the specific biological products of interest during various PMIs and under different post-mortem conditions prior to performing a similar analysis in human post-mortem brain specimens. Importantly, it must be kept in mind that there exists the possibility that protein and protein phosphorylation in the human brain may not degrade at the same rate or at the same manner as in the mouse brain. A valuable resource may be the availability of human post-mortem brain tissue with experimentally defined post-mortem storage timesFand other post-mortem factorsFfrom the same individual (to limit human heterogeneity). The availability of such a repository would allow for more scientifically rigorous testing of the effects of posmortem factors than is currently available when utilizing post hoc correlational analyses.
Clearly, the human post-mortem brain represents a tremendously important resource for the study of neuropsychiatric disorders (Duman, 2002) . However, care must be taken to ascertain the effect of PMI on protein levels, or post-translational forms of proteins under investigation. While PMIs generally found in most studies may be adequate to quantitate the total levels of many proteins, extreme caution is likely required in the interpretation of phosphoprotein levels, two-dimensional gel electrophoresis, and the activity of enzymes regulated by phosphorylation.
